GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,049,000 | -97.9% | 41,719 | -98.9% | 0.00% | -98.2% |
| Q4 2020 | $431,196,000 | +18.7% | 3,736,209 | +0.1% | 0.11% | +2.8% |
| Q3 2020 | $363,380,000 | -20.1% | 3,732,712 | +0.7% | 0.11% | -24.3% |
| Q2 2020 | $455,004,000 | +40.2% | 3,707,662 | +0.0% | 0.14% | +13.4% |
| Q1 2020 | $324,631,000 | -14.3% | 3,707,103 | +2.3% | 0.13% | +11.4% |
| Q4 2019 | $378,824,000 | -8.7% | 3,623,067 | +0.4% | 0.11% | -16.2% |
| Q3 2019 | $415,072,000 | -33.3% | 3,608,370 | +0.0% | 0.14% | -31.0% |
| Q2 2019 | $621,951,000 | +2.3% | 3,607,812 | +0.0% | 0.20% | +2.1% |
| Q1 2019 | $608,061,000 | +73.1% | 3,607,171 | +0.0% | 0.19% | +58.2% |
| Q4 2018 | $351,302,000 | -39.8% | 3,607,168 | +6.9% | 0.12% | -27.8% |
| Q3 2018 | $583,098,000 | +23.8% | 3,375,580 | -0.0% | 0.17% | +31.0% |
| Q2 2018 | $471,049,000 | +23.9% | 3,375,724 | +0.0% | 0.13% | +19.4% |
| Q1 2018 | $380,328,000 | -14.7% | 3,375,596 | 0.0% | 0.11% | -17.6% |
| Q4 2017 | $445,612,000 | +44.4% | 3,375,596 | +11.0% | 0.13% | +40.9% |
| Q3 2017 | $308,568,000 | +1.8% | 3,040,380 | +0.5% | 0.09% | -2.1% |
| Q2 2017 | $303,214,000 | -16.9% | 3,024,580 | +0.2% | 0.10% | -17.4% |
| Q1 2017 | $364,949,000 | +8.2% | 3,017,604 | 0.0% | 0.12% | +5.5% |
| Q4 2016 | $337,217,000 | -15.8% | 3,017,604 | 0.0% | 0.11% | -17.4% |
| Q3 2016 | $400,527,000 | +66.5% | 3,017,604 | +14.9% | 0.13% | +61.0% |
| Q2 2016 | $240,525,000 | +27.7% | 2,626,674 | +0.6% | 0.08% | +26.2% |
| Q1 2016 | $188,360,000 | +3.9% | 2,610,674 | 0.0% | 0.06% | +4.8% |
| Q4 2015 | $181,285,000 | -24.0% | 2,610,674 | 0.0% | 0.06% | -27.1% |
| Q3 2015 | $238,537,000 | -25.2% | 2,610,674 | +0.6% | 0.08% | -19.0% |
| Q2 2015 | $318,877,000 | +70.6% | 2,595,874 | +26.5% | 0.10% | +64.1% |
| Q1 2015 | $186,933,000 | +34.6% | 2,051,274 | 0.0% | 0.06% | +36.2% |
| Q4 2014 | $138,830,000 | -16.2% | 2,051,274 | +0.1% | 0.05% | -17.5% |
| Q3 2014 | $165,647,000 | -17.1% | 2,048,820 | +10.0% | 0.06% | -18.6% |
| Q2 2014 | $199,892,000 | +316.4% | 1,863,100 | +130.4% | 0.07% | +311.8% |
| Q1 2014 | $48,001,000 | – | 808,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |